Takeda Pharmaceutical Co Ltd 20-F for FY2023
Takeda Pharmaceutical Co Ltd (TAK)
20-F
2023-06-28
For: 2023-03-31
View Original
Added on
April 07, 2026
About this 20-F
Takeda Pharmaceutical Co Ltd filed this 20-F on June 28, 2023, covering the fiscal year ended March 31, 2023 (FY2023).
Headline figures
Fiscal year ended March 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 4.03T JPY
- up 12.8% from 3.57T JPY a year earlier
- Net income
- 317.02B JPY
- up 37.8% from net income of 230.06B JPY a year earlier
- Diluted EPS
- 201.94 JPY
- up 38.4% from 145.87 JPY a year earlier